Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

Europe - AMS:AZRN - NL00150006Z9 - Common Stock

1.365 EUR
-0.01 (-0.73%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

1

AZRN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 22 industry peers in the Interactive Media & Services industry. AZRN may be in some trouble as it scores bad on both profitability and health. AZRN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AZRN had negative earnings in the past year.
AZRN had a negative operating cash flow in the past year.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

The Return On Assets of AZRN (-7.83%) is worse than 72.73% of its industry peers.
AZRN has a worse Return On Equity (-176.07%) than 72.73% of its industry peers.
Industry RankSector Rank
ROA -7.83%
ROE -176.07%
ROIC N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 31.93%, AZRN is doing worse than 72.73% of the companies in the same industry.
AZRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZRN has been increased compared to 1 year ago.
AZRN has a worse debt/assets ratio than last year.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that AZRN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AZRN (0.64) is worse than 63.64% of its industry peers.
A Debt/Equity ratio of 9.33 is on the high side and indicates that AZRN has dependencies on debt financing.
The Debt to Equity ratio of AZRN (9.33) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.33
Debt/FCF N/A
Altman-Z 0.64
ROIC/WACCN/A
WACC8.25%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

AZRN has a Current Ratio of 0.90. This is a bad value and indicates that AZRN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.90, AZRN is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
AZRN has a Quick Ratio of 0.90. This is a bad value and indicates that AZRN is not financially healthy enough and could expect problems in meeting its short term obligations.
AZRN's Quick ratio of 0.90 is on the low side compared to the rest of the industry. AZRN is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

AZRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -403.49%.
Looking at the last year, AZRN shows a small growth in Revenue. The Revenue has grown by 3.30% in the last year.
EPS 1Y (TTM)-403.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.76%
Revenue 1Y (TTM)3.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%

3.2 Future

AZRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.00% yearly.
AZRN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.50% yearly.
EPS Next Y190%
EPS Next 2Y84.39%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue Next Year10.58%
Revenue Next 2Y8.99%
Revenue Next 3Y8.5%
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZRN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 9.56 indicates a reasonable valuation of AZRN.
100.00% of the companies in the same industry are more expensive than AZRN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AZRN to the average of the S&P500 Index (22.73), we can say AZRN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.56
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZRN indicates a rather cheap valuation: AZRN is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.08
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AZRN's earnings are expected to grow with 71.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.39%
EPS Next 3Y71%

More info and screens

0

5. Dividend

5.1 Amount

AZRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZERION GROUP N.V.

AMS:AZRN (9/12/2025, 7:00:00 PM)

1.365

-0.01 (-0.73%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-28 2025-08-28
Earnings (Next)11-18 2025-11-18
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners45.38%
Ins Owner ChangeN/A
Market Cap167.72M
Analysts82.86
Price Target2.04 (49.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)550%
EPS NY rev (3m)550%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.56
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 5.99
P/tB N/A
EV/EBITDA 11.08
EPS(TTM)-0.41
EYN/A
EPS(NY)0.14
Fwd EY10.46%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS4.53
BVpS0.23
TBVpS-2.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.83%
ROE -176.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.93%
FCFM N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 9.33
Debt/FCF N/A
Debt/EBITDA 7.68
Cap/Depr 39.81%
Cap/Sales 3.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z 0.64
F-Score4
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)51.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-403.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.76%
EPS Next Y190%
EPS Next 2Y84.39%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue 1Y (TTM)3.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%
Revenue Next Year10.58%
Revenue Next 2Y8.99%
Revenue Next 3Y8.5%
Revenue Next 5YN/A
EBIT growth 1Y-126.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55%
EBIT Next 3Y27.65%
EBIT Next 5YN/A
FCF growth 1Y-153.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.73%
OCF growth 3YN/A
OCF growth 5YN/A